Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis-Reference-Cited by-同舟云学术

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

Published:2001-05 Issue:7 Volume:37 Page:835-842
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Cocquyt V,Van Belle S,Reinhardt R.R,Decramer M.L.A,O'Brien M,Schellens J.H.M,Borms M,Verbeke L,Van Aelst F,De Smet M,Carides A.D,Eldridge K,Gertz B.J

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. On the receiving end V;Griffin;Ann. Oncol.,1997

2. Quality of life studies in chemotherapy-induced emesis;Osoba;Oncology,1996

3. Emesis as a critical problem in chemotherapy;Laszlo;N. Engl. J. Med.,1981

4. Controlling emesis in patients receiving cancer chemotherapy;Gralla;Recent Results Cancer Res.,1991

5. The management of chemotherapy-induced nausea and vomiting;Gralla;Med Clin. North Am.,1987

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental analysis and modeling of aprepitant (an antiemetic drug for chemotherapy) solubility in subcritical water with/without co-solvent;The Journal of Supercritical Fluids;2024-11

2. Preparation of Aprepitant nanoparticles using subcritical water anti-solvent technology;Powder Technology;2024-11

3. An assessment of the effects of neurokinin₁ receptor antagonism against nausea and vomiting: Relative efficacy, sites of action and lessons for future drug development;British Journal of Clinical Pharmacology;2023-08-17

4. Fabrication of an aprepitant nanosuspension using hydroxypropyl chitosan to increase the bioavailability;Biochemical and Biophysical Research Communications;2022-11

5. Preparation and Characterization of Aprepitant Solid Dispersion with HPMCAS-LF;ACS Omega;2022-10-24